AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE Airfinity provides real time life science intelligence as a subscription service. Therapy area relevant information in one easy-to-navigate platform updated multiple times daily. In depth forecasts, insights and meta-science briefings. A daily curated newsletter and hotline access to AIRFINITY – NEWSROOM, COVID-19 AND VACCINES NEWS ARTICLES The row between the EU and the UK has grabbed the limelight, but the issues go further and deeper and supply chains across the world are being affected. On BBC Newsnight Rasmus Hansen, Airfinity CEO, is asked by Political Editor Nick Watt how vaccine protectionism sits with every nation's desire to keep its people safe. Published by BBC

Newsnight.

AIRFINITY – PREDICTIONS PREDICTIONS OF PHASE 3 TRIAL READOUTS. Forecasting the timings of large trials is critical for all parts of the life science ecosystem. By combining granular data on trial locations, disease prevalence and end points, we are able to accurately predict read out dates for interim and full analysis for a number of Phase 3 COVID-19 vaccine trials and also infer accurate efficacy estimates from the AIRFINITY – CAREERS Working at Airfinity. At Airfinity we work in high impact scientific disciplines, where substantial problems are still unsolved. This is a privilege that comes with an obligation to perform to the highest level. We offer a fast-paced, dynamic and intellectually stimulating work environment. We AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE New science is the engine of progress. Airfinity is the tool to unlock

the future.

VIRTUAL CONFERENCE ANALYTICS Virtual conference analytics. Data driven intelligence to measure and maximise your "virtual" conference Share of Voice. In light of the Covid-19 pandemic all major scientific events have been forced to either cancel or go fully online. Increasingly organisers are choosing the latter and evolving into fully blown virtual congresses.

AIRFINITY INSIGHTS

LONDON, United Kingdom | ST, GALLEN, Switzerland – March 31, 2021 The St. Gallen Endowment and Airfinity today announced their partnership to jointly produce topical thought leadership on the fast-moving developments affecting the production, export, and distribution of COVID-19 vaccines.. Today’s thought leadership piece “Halting India’s Vaccine Exports: The Fallout” is the initial

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting ONCOLOGY - AIRFINITY Oncology. The second largest cause of death is cancer and it’s the therapy area with the highest amount of R&D spend. This significant investment reflects the expectation of a number of critical breakthroughs in the coming years that will significantly reduce human suffering. Cancers can arise in many parts of the body, leading to a

range of

CARDIO-METABOLIC & VASCULAR The conditions that affect most people in the western world are cardio-metabolic and vascular. Ageing demographics and the fact that we now survive an increasing number of other diseases, renders people more vulnerable to cardiovascular problems. Obesity and, consequently, Type-2 diabetes are becoming globalised, resulting in a pervasive risk AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE Airfinity provides real time life science intelligence as a subscription service. Therapy area relevant information in one easy-to-navigate platform updated multiple times daily. In depth forecasts, insights and meta-science briefings. A daily curated newsletter and hotline access to AIRFINITY – NEWSROOM, COVID-19 AND VACCINES NEWS ARTICLES The row between the EU and the UK has grabbed the limelight, but the issues go further and deeper and supply chains across the world are being affected. On BBC Newsnight Rasmus Hansen, Airfinity CEO, is asked by Political Editor Nick Watt how vaccine protectionism sits with every nation's desire to keep its people safe. Published by BBC

Newsnight.

AIRFINITY – PREDICTIONS PREDICTIONS OF PHASE 3 TRIAL READOUTS. Forecasting the timings of large trials is critical for all parts of the life science ecosystem. By combining granular data on trial locations, disease prevalence and end points, we are able to accurately predict read out dates for interim and full analysis for a number of Phase 3 COVID-19 vaccine trials and also infer accurate efficacy estimates from the AIRFINITY – CAREERS Working at Airfinity. At Airfinity we work in high impact scientific disciplines, where substantial problems are still unsolved. This is a privilege that comes with an obligation to perform to the highest level. We offer a fast-paced, dynamic and intellectually stimulating work environment. We AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE New science is the engine of progress. Airfinity is the tool to unlock

the future.

VIRTUAL CONFERENCE ANALYTICS Virtual conference analytics. Data driven intelligence to measure and maximise your "virtual" conference Share of Voice. In light of the Covid-19 pandemic all major scientific events have been forced to either cancel or go fully online. Increasingly organisers are choosing the latter and evolving into fully blown virtual congresses.

AIRFINITY INSIGHTS

LONDON, United Kingdom | ST, GALLEN, Switzerland – March 31, 2021 The St. Gallen Endowment and Airfinity today announced their partnership to jointly produce topical thought leadership on the fast-moving developments affecting the production, export, and distribution of COVID-19 vaccines.. Today’s thought leadership piece “Halting India’s Vaccine Exports: The Fallout” is the initial

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting ONCOLOGY - AIRFINITY Oncology. The second largest cause of death is cancer and it’s the therapy area with the highest amount of R&D spend. This significant investment reflects the expectation of a number of critical breakthroughs in the coming years that will significantly reduce human suffering. Cancers can arise in many parts of the body, leading to a

range of

CARDIO-METABOLIC & VASCULAR The conditions that affect most people in the western world are cardio-metabolic and vascular. Ageing demographics and the fact that we now survive an increasing number of other diseases, renders people more vulnerable to cardiovascular problems. Obesity and, consequently, Type-2 diabetes are becoming globalised, resulting in a pervasive risk

AIRFINITY INSIGHTS

Production necessary to vaccinate the U.S. adult population should be completed by 20 June 2021. Following that a surplus of 500 million doses would have accumulated by 25 September 2021. These two dates move back to 18 July 2021 and 18 October 2021, respectively, if American children are inoculated as well.

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting SOLUTIONS FOR PHARMA & BIOTECH Book a meeting with one of our analysts. We deliver critical data, information and insights to global decision makers across pharmaceuticals, med- and biotech companies, governments, corporates and investors. Discuss your use case for our data and your business needs. Give a thorough demonstration of our platform, products and

solutions.

SCIENCEMACRO

ScienceMacro is based on Airfinity’s market leading Covid-19 science information and analytics solution. It combines data from a range of complex sources to deliver advanced machine-learning driven short term forecast models. Our predictions have been proven within a 10% margin of error, making our risk indicators amongst the most reliable in SCIENCE360 - AIRFINITY Access all new science from conferences, preprints, journals and trials with impact indicators to alert you to new developments. Identify high impact upcoming or recent research within a given drug class or therapy area. Track independent researchers and receive notification of KOL activities. Access all media, press releases, web

and social

AIRFINITY INSIGHTS

Fig. 1: View of Airfinity’s candidate efficacy comparison tool. As the lipids measured in clinical trials differ between candidates, those investigated have been highlighted per candidate and coloured according to their change from baseline after treatment. CHIEF FINANCIAL OFFICER Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights.

EPIDEMIOLOGIST

Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights.

FRONTEND DEVELOPER

Airfinity is a predictive science intelligence company. Working with some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. BOOKKEEPER - AIRFINITY Bookkeeper. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. We are seeking a bookkeeper with experience of B2B subscription services. AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE Airfinity provides real time life science intelligence as a subscription service. Therapy area relevant information in one easy-to-navigate platform updated multiple times daily. In depth forecasts, insights and meta-science briefings. A daily curated newsletter and hotline access to AIRFINITY – PREDICTIONS PREDICTIONS OF PHASE 3 TRIAL READOUTS. Forecasting the timings of large trials is critical for all parts of the life science ecosystem. By combining granular data on trial locations, disease prevalence and end points, we are able to accurately predict read out dates for interim and full analysis for a number of Phase 3 COVID-19 vaccine trials and also infer accurate efficacy estimates from the AIRFINITY – NEWSROOM The row between the EU and the UK has grabbed the limelight, but the issues go further and deeper and supply chains across the world are being affected. On BBC Newsnight Rasmus Hansen, Airfinity CEO, is asked by Political Editor Nick Watt how vaccine protectionism sits with every nation's desire to keep its people safe. Published by BBC

Newsnight.

AIRFINITY – CAREERS Working at Airfinity. At Airfinity we work in high impact scientific disciplines, where substantial problems are still unsolved. This is a privilege that comes with an obligation to perform to the highest level. We offer a fast-paced, dynamic and intellectually stimulating work environment. We CONTACT US - AIRFINITY Airfinity is a science information and analytics company. Working with the entire ecosystem; pharma companies, governments, investors and media, we have become an authoritative provider of new life science intelligence. Our subscription platform delivers therapy area and drug specific data, insights and predictive forecasts in real time. VIRTUAL CONFERENCE ANALYTICS Virtual conference analytics. Data driven intelligence to measure and maximise your "virtual" conference Share of Voice. In light of the Covid-19 pandemic all major scientific events have been forced to either cancel or go fully online. Increasingly organisers are choosing the latter and evolving into fully blown virtual congresses. SOLUTIONS FOR PHARMA & BIOTECH Book a meeting with one of our analysts. We deliver critical data, information and insights to global decision makers across pharmaceuticals, med- and biotech companies, governments, corporates and investors. Discuss your use case for our data and your business needs. Give a thorough demonstration of our platform, products and

solutions.

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting LIFE SCIENCE RESEARCHER Life Science Researcher. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. Airfinity is headquartered in London, UK (though we are

currently working

BOOKKEEPER - AIRFINITY Bookkeeper. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. We are seeking a bookkeeper with experience of B2B subscription services. AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE Airfinity provides real time life science intelligence as a subscription service. Therapy area relevant information in one easy-to-navigate platform updated multiple times daily. In depth forecasts, insights and meta-science briefings. A daily curated newsletter and hotline access to AIRFINITY – PREDICTIONS PREDICTIONS OF PHASE 3 TRIAL READOUTS. Forecasting the timings of large trials is critical for all parts of the life science ecosystem. By combining granular data on trial locations, disease prevalence and end points, we are able to accurately predict read out dates for interim and full analysis for a number of Phase 3 COVID-19 vaccine trials and also infer accurate efficacy estimates from the AIRFINITY – NEWSROOM The row between the EU and the UK has grabbed the limelight, but the issues go further and deeper and supply chains across the world are being affected. On BBC Newsnight Rasmus Hansen, Airfinity CEO, is asked by Political Editor Nick Watt how vaccine protectionism sits with every nation's desire to keep its people safe. Published by BBC

Newsnight.

AIRFINITY – CAREERS Working at Airfinity. At Airfinity we work in high impact scientific disciplines, where substantial problems are still unsolved. This is a privilege that comes with an obligation to perform to the highest level. We offer a fast-paced, dynamic and intellectually stimulating work environment. We CONTACT US - AIRFINITY Airfinity is a science information and analytics company. Working with the entire ecosystem; pharma companies, governments, investors and media, we have become an authoritative provider of new life science intelligence. Our subscription platform delivers therapy area and drug specific data, insights and predictive forecasts in real time. VIRTUAL CONFERENCE ANALYTICS Virtual conference analytics. Data driven intelligence to measure and maximise your "virtual" conference Share of Voice. In light of the Covid-19 pandemic all major scientific events have been forced to either cancel or go fully online. Increasingly organisers are choosing the latter and evolving into fully blown virtual congresses. SOLUTIONS FOR PHARMA & BIOTECH Book a meeting with one of our analysts. We deliver critical data, information and insights to global decision makers across pharmaceuticals, med- and biotech companies, governments, corporates and investors. Discuss your use case for our data and your business needs. Give a thorough demonstration of our platform, products and

solutions.

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting LIFE SCIENCE RESEARCHER Life Science Researcher. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. Airfinity is headquartered in London, UK (though we are

currently working

BOOKKEEPER - AIRFINITY Bookkeeper. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. We are seeking a bookkeeper with experience of B2B subscription services. AIRFINITY – PREDICTIVE SCIENCE INTELLIGENCE New science is the engine of progress. Airfinity is the tool to unlock

the future.

SCIENCEMACRO

ScienceMacro is based on Airfinity’s market leading Covid-19 science information and analytics solution. It combines data from a range of complex sources to deliver advanced machine-learning driven short term forecast models. Our predictions have been proven within a 10% margin of error, making our risk indicators amongst the most reliable in

AIRFINITY INSIGHTS

Global Vaccination Forecast. The map shows our global forecast on when each country could achieve certain proportions of their population to be fully vaccinated throughout the year. The data is based on existing supply deals and production scale up, highlighting which countries will be getting vaccinated first and which regions will be waiting

AIRFINITY INSIGHTS

LONDON, United Kingdom | ST, GALLEN, Switzerland – March 31, 2021 The St. Gallen Endowment and Airfinity today announced their partnership to jointly produce topical thought leadership on the fast-moving developments affecting the production, export, and distribution of COVID-19 vaccines.. Today’s thought leadership piece “Halting India’s Vaccine Exports: The Fallout” is the initial SOLUTIONS FOR MULTI-NATIONALS Multi-nationals face the risk of unprecedented disruptions from infectious diseases to their supply chains, demand side dynamics and workforce itself. Pandemics are an ongoing liability all companies need to manage. Airfinity provides management level insights and data to help forecast and better mitigate infectious disease related risks.

HR ADMINISTRATOR

Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. CARDIO-METABOLIC & VASCULAR The conditions that affect most people in the western world are cardio-metabolic and vascular. Ageing demographics and the fact that we now survive an increasing number of other diseases, renders people more vulnerable to cardiovascular problems. Obesity and, consequently, Type-2 diabetes are becoming globalised, resulting in a pervasive risk CHIEF FINANCIAL OFFICER Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights.

FRONTEND DEVELOPER

Airfinity is a predictive science intelligence company. Working with some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. DATA ENTRY SPECIALIST Data Entry Specialist. Airfinity is a science information and analytics company. Working for some of the world’s largest pharmaceuticals, governments and investors, the company has established itself as authoritative provider of predictive, actionable insights. At Airfinity you will get a chance to work on some of the

most important

Access the world's trusted COVID-19 data today

Coverage

Cardio-metabolic & Vascular

COVID-19

Oncology

Solutions for

Asset Managers & Banks Governments & Healthcare Authorities International Organisations & NGOs

Medtech

Multi-nationals

Pharma & Biotech

Research institutions

Products

Science360

ScienceMacro

ScienceSoV

Newsroom

In the News

Predictions

Insights

About

Company

Team

Careers

Contact us

Login

PREDICTIVE SCIENCE INTELLIGENCE New science is the engine of progress. Airfinity is the tool to unlock

the future.

Trusted by

Featured in more than 200 newspapers, journals and on TV networks

worldwide

AIRFINITY PROVIDES REAL TIME LIFE SCIENCE INTELLIGENCE AS A SUBSCRIPTION SERVICE * Therapy area relevant information in one easy-to-navigate platform updated multiple times daily * In depth forecasts, insights and meta-science briefings * A daily curated newsletter and hotline access to therapy specialised analysts

Start today

WHY AIRFINITY

FIRST

We collect data from the earliest sources which allows us to provide decision makers with the most up-to-date comprehensive and granular intelligence on critical new scientific developments in real-time.

PREDICTIVE

By turning millions of fragmented science-related data points into a structured data set we build dynamic forecasts models and simulations for trial readouts, approval likelihood, production, pricing and more to provide better decision making tools.

ACCURATE

All information is classified and analysed by specialised experts ensuring the highest standards and quality. Our analyst team consist of some of the most talented scientists of their generation, top KOLs and industry veterans. We are fiercely independent and data driven.

HOW WE DO IT

DAILY COMPOUND-CENTRIC ANALYSIS We monitor thousands of sources in all major languages to have a molecular or disease centric view and set of impact metrics. All preclinical and clinical compounds covered. DATABASE ACCESS TO DISEASE PREVALENCE, PRODUCTION, SUPPLY & FUNDING Though public sources and data partnerships, we collect unstructured signals on production, supply, deals, infections, government and company level policies.

DYNAMIC SIMULATIONS

Our forecast models for trial read outs, production and immunisations are updated as new information is available. We can integrate with our clients’ own data streams to create custom predictors. SIGN UP TO RECEIVE A BIWEEKLY SAMPLE OF OUR INSIGHTS

Sign up

Free for 3 months for verified organisations only. To schedule a demo today, contact us . To receive our media briefings, email press@airfinity.com.

WHO WE SERVE

ASSET MANAGERS & BANKS Identify alpha rich investment opportunities with deep analysis of new scientific trends, players and technologies impacting the industry’s

value chain.

GOVERNMENTS & HEALTHCARE AUTHORITIES Monitor new science to inform national biosecurity strategies, funding allocations and procurement decisions across} defence, health and

science ministries.

INTERNATIONAL ORGANISATIONS & NGOS Make data driven funding and strategic decisions on emerging therapeutics to improve disease response and horizon scan the broader new science landscape.

MEDTECH

Get structured predictive industry, competitor and scientific intelligence to inform key decisions across the life cycle and empower your go-to-market strategy.

MULTI-NATIONALS

Manage your infectious disease risk. Access country level forecasts of disease prevalence with an overview of treatments and vaccines. Combine our intelligence with your own data on workforce demographics and supply chains to act in time to protect employee health and avoid

disruptions.

PHARMA & BIOTECH

Get structured, predictive market and scientific intelligence to inform key decisions across the life cycle from R&D, supply through medical affairs to commercial. RESEARCH INSTITUTIONS Enrich academic research and analysis with access to a real time, comprehensive and structured data set covering all new scientific developments in a given therapy area.

IN THE NEWS

Jun

1

CORONAVAC IS ALREADY USED IN 36 COUNTRIES Published by Valor Econômico

Jun

1

COVID 19 CORONAVIRUS: WHY THE GLOBAL VACCINE ROLLOUT IS SO HARD - AND WHAT WE CAN DO ABOUT IT Published by NZ Herald

Jun

1

THE DANISH HEALTH AND MEDICINES AUTHORITY EXPECTS TO VACCINATE 260,000 WITH A VACCINE THAT HAS NOT YET BEEN APPROVED

Published by TV 2

Jun

1

VACCINATING THE WORLD: THE OBSTACLES HINDERING GLOBAL ROLLOUT – AND HOW TO OVERCOME THEM Published by The Telegraph

Jun

1

WHO VALIDATES SECOND CHINESE JAB, HOPING TO PROVIDE BOOST FOR COVAX Published by China Daily

May

30

OVER-50S TO HAVE SECOND VACCINE IN RACE TO SAVE JUNE 21 Published by The Times

May

27

COVID ORIGIN HUNT ORDERED; MELBOURNE TO LOCK DOWN: VIRUS UPDATE Published by The Washington Post

May

26

COVID-19 VACCINE MAKERS PRESS COUNTRIES TO OPPOSE PATENT WAIVER Published by Wall Street Journal

May

26

COVID SHOT MAKERS TO SHARE IN UP TO $190 BILLION SALES BONANZA Published by Bloomberg

May

25

VACCINE PRODUCTION: HOW MUCH IS EXPORTED? Published by Statista

See all press

COVERAGE

Cardio-metabolic & Vascular

COVID-19

Oncology

WHO WE SERVE

Asset Managers & Banks Governments & Healthcare Authorities International Organisations & NGOs

Medtech

Multi-nationals

Pharma & Biotech

Research institutions

PRODUCTS

Science360

ScienceMacro

ScienceSoV

NEWSROOM

In The News

Predictions

Insights

COMPANY

About

Team

Careers

Newsroom

Contact

Copyright © Airfinity Limited 2021. Privacy Policy